Pharmaceutical

How a Cave Experiment Revealed Our Biological Clock
Clinical & Pharma How a Cave Experiment Revealed Our Biological Clock

The intricate rhythm of day and night has governed life on Earth for eons, yet one French scientist’s daring descent into the planet’s depths revealed that a far more personal timepiece ticks within us all. In 1962, Michel Siffre embarked on a journey of self-experimentation that fundamentally

Funding Cuts Threaten Breakthrough Breast Cancer Research
Clinical & Pharma Funding Cuts Threaten Breakthrough Breast Cancer Research

In a laboratory at Harvard Medical School, rows of pink-lidded jars hold not just donated breast tissue samples, but the potential to prevent a disease that will affect one in eight American women. For years, this lab, led by renowned cancer researcher Dr. Joan Brugge, has been meticulously working

Is Nepal Prepared for a Nipah Virus Outbreak?
Clinical & Pharma Is Nepal Prepared for a Nipah Virus Outbreak?

The emergence of a deadly Nipah virus outbreak in neighboring India has cast a long shadow across the border, compelling Nepal's Ministry of Health and Population to issue a sweeping public health advisory. While the World Health Organization (WHO) currently assesses the public health risk to the

Is This Namibia's Path to Universal Healthcare?
Clinical & Pharma Is This Namibia's Path to Universal Healthcare?

The Namibian government is moving forward with a transformative healthcare reform, presenting a Universal Health Coverage (UHC) bill that aims to bridge the significant gap between the nation's public and private health sectors. The Ministry of Health and Social Services has initiated a crucial

Canadian Trial Tests Novel Cream to Reduce Burn Scars
Clinical & Pharma Canadian Trial Tests Novel Cream to Reduce Burn Scars

For individuals who have survived severe burn injuries, the initial trauma is often just the beginning of a long and arduous journey, with the subsequent scarring presenting a formidable, lifelong challenge. These scars can do more than alter one's appearance; they frequently cause chronic pain and

Why Is AstraZeneca Betting $15 Billion on China?
Clinical & Pharma Why Is AstraZeneca Betting $15 Billion on China?

In a move that reverberates across the global pharmaceutical landscape, AstraZeneca has committed to a monumental $15 billion long-term investment in China, signaling a profound strategic alignment with the nation's rapidly ascending role as a biopharmaceutical powerhouse. This massive financial

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later